✦ LIBER ✦

Low-Dose Azacitidine (AZA) As Maintenence Therapy After Allogeneic Hematopoietic Stem Transplantation (HSCT) In Relapsed AML Or MDS: A Nursing Perspective

✍ Scribed by L.J. Metoyer; R. Champlin; A. Gulbis; L. da Silva; M. de Lima; S. Giralt

Book ID: 116280958
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 46 KB
Volume: 15
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2008.12.464

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

302: An Evaluation of DNA Methylation Ch

302: An Evaluation of DNA Methylation Changes in a Phase I Clinical Trial of Low-dose 5-azacitidine (AZA) given as Maintenance Therapy after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

✍ L. Silva; G. Garcia-Manero; S. Giralt; G. McCormick; A. Soriano; R. Champlin; H. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Maintenance therapy with low-dose azacit

Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome : A dose and schedule finding study

✍ Marcos de Lima; Sergio Giralt; Peter F. Thall; Leandro de Padua Silva; Roy B. Jo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 388 KB 👁 1 views

Combining Azacitidine (Vidaza®, Aza) and

Combining Azacitidine (Vidaza®, Aza) and Donor Lymphocyte Infusions (DLI) as First Salvage Treatment in Patients (PTS) With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS) Relapsing After Allogeneic Hematopoietic Stem Cell Transplantation (allo-SCT): Interim-Analysis From the Azarela-Trial (NCT-00795548)

✍ T. Schroeder; A.G. Czibere; N. Kröger; U. Platzbecker; G. Bug; L. Uharek; T. Luf 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 63 KB